Skip to main content
See every side of every news story
Published loading...Updated

Idaho Doctors Respond to Federal Warning on Tylenol Use in Pregnancy, Possible Autism Link

HHS plans to add a warning label to acetaminophen for pregnant women despite experts citing inconclusive evidence and complex autism causes, including genetics and environment.

  • On 22 September 2025, Robert F. Kennedy Jr., Secretary of Health and Human Services, announced HHS would add a warning label to acetaminophen and notify doctors to reduce use in pregnancy.
  • Earlier this year, the Centers for Disease Control and Prevention reported 1 in 31 eight-year-olds had an ASD diagnosis in 2022, up from 1 in 36 in 2020.
  • Experts and scientific groups said the September 22 press conference alarmed researchers and cited a nearly 2.5 million children Swedish study showing associations could be explained by other factors.
  • The Food and Drug Administration said it will approve leucovorin for cerebral folate deficiency and Mehmet Oz confirmed coverage, while the National Institutes of Health launched a $50 million Autism Data Science Initiative and Kenvue Inc. shares fell nearly 7.5%.
  • Federal court rulings centralized Tylenol lawsuits into an MDL before U.S. District Judge Denise Cote, who excluded plaintiffs' experts for unsound methods, while ACOG and regulators warn against switching drugs and clinicians caution untreated fevers risk unborn children.
Insights by Ground AI

14 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left
50% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

U.S. News broke the news in New York, United States on Monday, September 22, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal